Wild-type, but not mutant N296H, human tau restores Aβ-mediated inhibition of LTP in tau(-/-) mice
Microtubule associated protein tau (MAPT) is involved in the pathogenesis of Alzheimer's disease and many forms of frontotemporal dementia (FTD). We recently reported that Aβ-mediated inhibition of hippocampal long-term potentiation (LTP) in mice requires tau. Here, we asked whether expression...
Main Authors: | Vargas-Caballero, M, Denk, F, Wobst, H, Arch, E, Pegasiou, C, Oliver, P, Shipton, O, Paulsen, O, Wade-Martins, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2017
|
Similar Items
-
Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy.
by: Wobst, H, et al.
Published: (2017) -
Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation.
by: Shipton, O, et al.
Published: (2011) -
LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent
by: Daniela Puzzo, et al.
Published: (2017-07-01) -
Tau phosphorylation in cells transfected with wild-type or an Alzheimer's disease mutant Presenilin 1.
by: Irving, N, et al.
Published: (1997) -
Characterization of a Mouse Model of Alzheimer’s Disease Expressing Aβ4-42 and Human Mutant Tau
by: Silvia Zampar, et al.
Published: (2021-05-01)